2006
DOI: 10.1111/j.1432-2277.2006.00302.x
|View full text |Cite
|
Sign up to set email alerts
|

Rapid reversal of coagulopathy in patients on platelet aggregation inhibitors immediately prior to renal transplantation with recombinant factor VIIa?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…78 In another study, also involving healthy volunteers given aspirin plus clopidogrel, ex vivo rFVIIa reversed the inhibitory platelet effect of these agents. 3 In a letter to the editor, Loertzer et al 51 have described the prophylactic use of rFVIIa in 5 patients undergoing renal transplantation who were on aspirin or clopidogrel. These authors reported improvement in the coagulation parameters without thrombotic complications.…”
Section: Clopidogrelmentioning
confidence: 99%
“…78 In another study, also involving healthy volunteers given aspirin plus clopidogrel, ex vivo rFVIIa reversed the inhibitory platelet effect of these agents. 3 In a letter to the editor, Loertzer et al 51 have described the prophylactic use of rFVIIa in 5 patients undergoing renal transplantation who were on aspirin or clopidogrel. These authors reported improvement in the coagulation parameters without thrombotic complications.…”
Section: Clopidogrelmentioning
confidence: 99%